Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: COLONIC NEOPLASMS - DRUG THERAPY , . Treffer: 26

2016

Boehnke, K; Iversen, PW; Schumacher, D; Lallena, MJ; Haro, R; Amat, J; Haybaeck, J; Liebs, S; Lange, M; Schäfer, R; Regenbrecht, CR; Reinhard, C; Velasco, JA Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
J Biomol Screen. 2016; 21(9):931-941 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Bohanes, P; Yang, D; Loupakis, F; LaBonte, MJ; Gerger, A; Ning, Y; Lenz, C; Lenz, F; Wakatsuki, T; Zhang, W; Benhaim, L; El-Khoueiry, A; El-Khoueiry, R; Lenz, HJ Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Pharmacogenomics J. 2015; 15(3):226-234
Web of Science PubMed FullText FullText_MUG

 

Dehghan Esmatabadi, MJ; Farhangi, B; Safari, Z; Kazerooni, H; Shirzad, H; Zolghadr, F; Sadeghizadeh, M Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through Down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression.
Asian Pac J Cancer Prev. 2015; 16(6):2473-2481 [OPEN ACCESS]
PubMed

 

Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG) TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Páez, D; Gerger, A; Zhang, W; Yang, D; Labonte, MJ; Benhanim, L; Kahn, M; Lenz, F; Lenz, C; Ning, Y; Wakatsuki, T; Loupakis, F; Lenz, HJ Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.
Pharmacogenomics J. 2014; 14(2):142-150
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Kargl, J; Haybaeck, J; Stančić, A; Andersen, L; Marsche, G; Heinemann, A; Schicho, R O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.
J Mol Med (Berl). 2013; 91(4):449-458 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Reginato, E; Mroz, P; Chung, H; Kawakubo, M; Wolf, P; Hamblin, MR Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.
Br J Cancer. 2013; 109(8):2167-2174 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Betge, J; Langner, C; Rehak, P Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
Cancer. 2012; 118(8):2184; author reply 2184-2184; author reply 2185 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fröhlich, E; Wahl, R Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
Diabetes Obes Metab. 2012; 14(3): 204-213.
Web of Science PubMed FullText FullText_MUG

 

Pavliha, D; Kos, B; Zupanič, A; Marčan, M; Serša, G; Miklavčič, D Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls.
Bioelectrochemistry. 2012; 87(11): 265-273.
Web of Science PubMed FullText FullText_MUG

 

2011

Gerger, A; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Winder, T; LaBonte, MJ; Wilson, PM; Benhaim, L; Paez, D; El-Khoueiry, R; El-Khoueiry, A; Kahn, M; Lenz, HJ Common cancer stem cell gene variants predict colon cancer recurrence.
Clin Cancer Res. 2011; 17(21):6934-6943 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schicho, R; Storr, M Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
CAN J GASTROENTEROL. 2011; 25(7): 377-383. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Peter, S; Hausmann, N; Schuster, A; Boehm, HF Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab.
Clin Experiment Ophthalmol. 2008; 36(1):94-96 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2007

Schippinger, W; Samonigg, H; Schaberl-Moser, R; Greil, R; Thödtmann, R; Tschmelitsch, J; Jagoditsch, M; Steger, GG; Jakesz, R; Herbst, F; Hofbauer, F; Rabl, H; Wohlmuth, P; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
BRIT J CANCER. 2007; 97(8): 1021-1027. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2006

Goel, A; Fuerst, F; Hotchkiss, E; Boland, CR Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Cancer Biol Ther. 2006; 5(5):529-535 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2005

Schippinger, W; Jagoditsch, M; Sorré, C; Gnant, M; Steger, G; Hausmaninger, H; Mlineritsch, B; Schaberl-Moser, R; Mischinger, HJ; Hofbauer, F; Holzberger, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
BRIT J CANCER. 2005; 92(9): 1655-1662. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2002

Weber, T; Lu, M; Andera, L; Lahm, H; Gellert, N; Fariss, MW; Korinek, V; Sattler, W; Ucker, DS; Terman, A; Schröder, A; Erl, W; Brunk, UT; Coffey, RJ; Weber, C; Neuzil, J Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Clin Cancer Res. 2002; 8(3):863-869 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

2000

Auner, HW; Beham-Schmid, C; Lindner, G; Fickert, P; Linkesch, W; Sill, H Successful nonsurgical treatment of primary mucosa-associated lymphoid tissue lymphoma of colon presenting with multiple polypoid lesions.
Am J Gastroenterol. 2000; 95(9):2387-2389 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Stepan, VM; Sawada, M; Todisco, A; Dickinson, CJ Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.
Mol Med. 1999; 5(3):147-159 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

1996

Schaider, H; Haberkorn, U; Berger, MR; Oberdorfer, F; Morr, I; van Kaick, G Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.
Eur J Nucl Med. 1996; 23(1):55-60
Web of Science PubMed FullText FullText_MUG

 

1995

Schaider, H; Haberkorn, U; Petru, E; Berger, MR Combination treatment based on metabolic effects of dinaline.
J Cancer Res Clin Oncol. 1995; 121(4):203-210
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Zeiss, J; Merrick, HW; Savolaine, ER; Woldenberg, LS; Kim, K; Schlembach, PJ Fatty liver change as a result of hepatic artery infusion chemotherapy.
Am J Clin Oncol. 1990; 13(2):156-160 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum